Phan2017 - innate immune in oncolytic virotherapy Lab

{
  "io": {
    "inputs": [
      {
        "name": "initial_unresolved_tumor_observable_1",
        "label": "Initial Unresolved Tumor Observable 1",
        "units": "substance",
        "default": 0.99,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_1",
        "description": "Initial Unresolved Tumor Observable 1. Sets the initial value of bundled SBML species `x`."
      },
      {
        "name": "initial_unresolved_tumor_observable_2",
        "label": "Initial Unresolved Tumor Observable 2",
        "units": "substance",
        "default": 0.01,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_2",
        "description": "Initial Unresolved Tumor Observable 2. Sets the initial value of bundled SBML species `y`."
      },
      {
        "name": "initial_unresolved_tumor_observable_3",
        "label": "Initial Unresolved Tumor Observable 3",
        "units": "substance",
        "default": 0.01,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_3",
        "description": "Initial Unresolved Tumor Observable 3. Sets the initial value of bundled SBML species `v`."
      },
      {
        "name": "initial_unresolved_tumor_observable_4",
        "label": "Initial Unresolved Tumor Observable 4",
        "units": "substance",
        "default": 0.01,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_4",
        "description": "Initial Unresolved Tumor Observable 4. Sets the initial value of bundled SBML species `z`."
      },
      {
        "name": "infected_tumor_killing_rate",
        "label": "Infected Tumor Killing Rate",
        "units": "unit_0",
        "default": 0.48,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.infected_tumor_killing_rate",
        "description": "Infected Tumor Killing Rate. Sets bundled SBML parameter `c`."
      },
      {
        "name": "virus_killing_by_immune_rate",
        "label": "Virus Killing By Immune Rate",
        "units": "unit_0",
        "default": 0.16,
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.virus_killing_by_immune_rate",
        "description": "Virus Killing By Immune Rate. Sets bundled SBML parameter `d`."
      }
    ],
    "outputs": [
      {
        "name": "unresolved_tumor_observable_1",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_1"
      },
      {
        "name": "unresolved_tumor_observable_2",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_2"
      },
      {
        "name": "unresolved_tumor_observable_3",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_3"
      },
      {
        "name": "unresolved_tumor_observable_4",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_4"
      },
      {
        "name": "state",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.state"
      },
      {
        "name": "summary",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.summary"
      },
      {
        "name": "species_labels",
        "maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.species_labels"
      }
    ]
  },
  "title": "Phan2017 - innate immune in oncolytic virotherapy Lab",
  "models": [
    {
      "path": "models/core",
      "alias": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model"
    },
    {
      "path": "models/visualisation",
      "alias": "visualisation"
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_state"
      ],
      "from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.state"
    },
    {
      "to": [
        "visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_summary"
      ],
      "from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.summary"
    },
    {
      "to": [
        "visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_species_labels"
      ],
      "from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.species_labels"
    }
  ],
  "package": "phan2017-innate-immune-in-oncolytic-virotherapy",
  "runtime": {
    "duration": 10,
    "initial_inputs": {},
    "communication_step": 1
  },
  "version": "1.0.0",
  "description": "The paper describes a model on the key components for tumor–immune dynamics in multiple myeloma. Created by COPASI 4.25 (Build 207) This model is described in the article: The Role of the Innate Immun.",
  "schema_version": "2.0"
}